}
  • Icon Everyone is informed that if any person demands money in the name of providing any kind of job in AIIMS Nagpur, then immediately inform the AIIMS Administration on no.07103-295590 about that person.Despite this public notice, if any person gives money in the name of getting any kind of job in AIIMS Nagpur, then it will be his own responsibility.
  • Icon Appointment bookings shall be made exclusively through the eVaidya app. AIIMS Nagpur does not endorse any third-party private application for appointment scheduling.

Pulmonary Medicine Research and Publications

Funded Project

Duration: January 2025 to till date 

Funded Projects    

Sr. No.

 

Title of Project

Proposal No. (IEC No.)

Name of Principle Investigator

 

Amount of Grant Received

 

Name of Funding Agency

Collaboration with other institute (if any)

Status of Project (Ongoing/ Completed)

Publication (YES/NO)

1.

Magnitude and association of sleep related breathing disorders in adults with sickle cell disease: a cross sectional hospital based study from central India

1699

Dr Srikant K Malegaonkar

43,320 INR

Intramural – AIIMS NPR

Nil

Ongoing

No

  • Clinical Trials

Clinical Trials

 

Sr. No.

 

Title of Project

Clinical Trial No. 

Name of Principle Investigator

 

Amount Received

 

Sponsors

Status of Project (Ongoing/ Completed)

Publication (YES/NO)

1.

A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered dose inhaler Relative to Glycopyrronium and Formoterol Fumarate Metered dose inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease (THARROS)

NCT06283966

Dr Srikant K Malegaonkar

Invoice yet to raise

AstraZeneca

Ongoing

No

2.

A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (EMBARK)

NCT06883305

Dr Srikant K Malegaonkar

Yet to receive

AstraZeneca

Ongoing

No

3.

A randomized, open-label, active-controlled, parallel group, multicenter, Phase-Ill study to evaluate efficacy, safety and tolerability of Revefenacin inhalation solution 175 mcg versus Tiotropium dry powder for inhalation 18mcg in subjects with Chronic Obstructive Pulmonary Disease (COPD)

NCT02518139

Dr Srikant K Malegaonkar

Yet to receive

Cipla

Ongoing

No

4.

A Randomized, Double-Blind, Double-Dummy Clinical Trial Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Glycopyrronium, Formoterol, and Budesonide Nebulization Versus Pressurized Inhalation in Patients with Chronic Obstructive Pulmonary Disease

CTRI/2023/10/058675

Dr Srikant K Malegaonkar

7375 INR

Glenmark

Completed

No

  • Publications

Publication data for the year 2019 to 2023 should be in consolidated form (i.e. total count)

Dr Sryma P B-- 22

Dr Srikant K Malegaonkar à 6

Dr Palanisamy V--3

Details of publications 

Sr.No.

Publication

Year

Impact factor

1.

Malegaonkar SK. Rare presentation of pulmonary tuberculosis as diffuse alveolar hemorrhage. Indian Journal of Tuberculosis. 2024 Nov 5.

2024

0.9

2.

Malegaonkar SK. Finger-in-Glove Appearance. The Journal of Allergy and Clinical Immunology: In Practice. 2024 Nov 1;12(11):3126-7.

2024

11.2

3.

Vojjala N, Malegaonkar SK, Arora K, Sehgal IS, Pannu AK. Dual Toxidrome of Anti-cholinergic Storm and Neuroleptic Malignant Syndrome: A Therapeutic Challenge Overcome by Intrathecal Neostigmine. The Neurohospitalist. 2024 Oct;14(4):428-31.

2024

0.7

4.

Malegaonkar SK. Rare cause of hemoptysis: bronchial Dieulafoy’s disease—what not to do. Indian Journal of Thoracic and Cardiovascular Surgery. 2025 Jul;41(7):951-4.

2025

0.6

5.

Malegaonkar SK. Bronchus-Associated Lymphoid Tissue Lymphoma (BALToma) Treated as Pulmonary Tuberculosis Presenting with Stridor. Indian Journal of Hematology and Blood Transfusion. 2025 Feb 5:1-3.

2025

0.6

6.

Srikant KM. Intrapleural Tranexamic Acid In Haemothorax: A Case Report And Review Of Literature. Annals of Clinical and Medical Case Reports. 2025;14:1-3.

2025

NA

7.

Malegaonkar SK. Post-Obstructive Pulmonary Edema: A Different Type of Pulmonary Edema. Amrita Journal of Medicine. 2025 Jan 1;21(1):36-9.

2025

NA

8.

Malegaonkar SK. New-onset Mitral Valve Regurgitation Postbilateral Lung Transplantation–A Case Report. Indian Journal of Transplantation. 2025 Jan 1;19(1):117-8.

2025

0.2

9.

Srikant KM. Systemic Sclerosis Presenting as Chest Pain. J Glob Health Soci Med. 2025;1(1):1-2.

2025

NA

10.

Malegaonkar SK. 60-Year-Old Man With Recurrent Hemoptysis, Pulmonary Nodules, and Mediastinal Lymphadenopathy. CHEST Pulmonary. 2025 Jun 1;3(2).

2025

10.1

11.

Malegaonkar SK. Bronchoscopic Cryotherapy in Complicated Pulmonary Hydatid Cyst. American Journal of Respiratory and Critical Care Medicine. 2025 Jul 1(ja).

2025

19.4

12

Viswanath R, P B S, S K. Alternative Hybrid Technique of Intubation Using C-MAC and Yankauer Suction Catheter: Case of A Floppy Supraglottic Mass. Turk J Anaesthesiol Reanim. 2024 Jul 12;52(3):122-124.

2025

0.9

13

Anaesthetic management of robotic-assisted thoracoscopic thymectomy using the da Vinci system: A case series

R Viswanath, PB Sryma - Indian Journal of Clinical Anaesthesia, 2025

2025

NA

14

Utility of microRNA analysis in exhaled breath condensate of sarcoidosis and mediastinal tuberculosis patients: a pilot study

B Pattnaik, PB Sryma, N Bhatraju, S Mittal, S Arava… - ERJ Open Research, 2024

2024

4.3

15

Isoniazid-induced cerebellitis in a patient with renal dysfunction

P Janapreethi, PB Sryma, M Subramanian, G Vijay - Lung India, 2024

2024

1.2

16

Shock in the post-operative ICU: the etomidate enigma

R Viswanath, PB Sryma, S Krishnendu - Anaesthesiology Intensive Therapy, 2025

2025

1.3